Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medifast (MED) Assets Average (2016 - 2025)

Medifast's Assets Average history spans 15 years, with the latest figure at $258.1 million for Q4 2025.

  • For Q4 2025, Assets Average fell 10.3% year-over-year to $258.1 million; the TTM value through Dec 2025 reached $258.1 million, down 10.3%, while the annual FY2025 figure was $266.1 million, 10.42% down from the prior year.
  • Assets Average reached $258.1 million in Q4 2025 per MED's latest filing, down from $268.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $409.9 million in Q1 2022 to a low of $258.1 million in Q4 2025.
  • Average Assets Average over 5 years is $319.3 million, with a median of $316.9 million recorded in 2023.
  • Peak YoY movement for Assets Average: skyrocketed 59.05% in 2021, then fell 22.19% in 2023.
  • A 5-year view of Assets Average shows it stood at $384.8 million in 2021, then decreased by 16.52% to $321.3 million in 2022, then decreased by 1.97% to $315.0 million in 2023, then fell by 8.65% to $287.7 million in 2024, then dropped by 10.3% to $258.1 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Assets Average are $258.1 million (Q4 2025), $268.8 million (Q3 2025), and $274.7 million (Q2 2025).